Views & Analysis Health data security: report’s implications for pharma Data security issues that could have an impact on the pharma industry.
News Google DeepMind's blockchain for NHS health data to ease sec... Project aims to improve both patient data safety and auditability.
Views & Analysis Digital Health Round-up: Can digital resolve NHS' data secur... A round-up of this week's digital healthcare news. Marco Ricci reports.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.